Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

KS MSCI All China Health Care Index ETF (KURE)

$27.03 1.18 (4.57%)

20:00 EDT KURE Stock Quote Delayed 30 Minutes

Volume:

Previous Close $27.03

Market Cap 635,240

PE Ratio -

EPS -

Volume (Avg. Vol.) 91,800

Day's Range 26.47 - 27.39

52-Week Range 18.49 - 28.26

Dividend & Yield N/A (N/A)

KURE Stock Predictions, Articles, and KS MSCI All China Health Care Index ETF News

From the Web

Best & Worst Performing Large Cap Stocks for May 29, 2020

From StockNews.com May 29, 2020

ZS – ZS leads the way today as the best performing large cap stock, closing up 26.45%.

Noteworthy Friday Option Activity: LSI, TDOC, DPZ

From Market News Video May 29, 2020

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Life Storage Inc (LSI), where a total volume of 1,821 contracts has been traded thus far today, a contract volume which is representative of approximately 182,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 51.5% of LSI's average daily trading volume over the past month, of 353,675 shares..

Teladoc (TDOC) Up 1.4% Since Last Earnings Report: Can It Continue?

From Zacks Investment Research May 29, 2020

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

3 Stocks Poised For Huge Growth Over the Next Decade

From The Motley Fool May 28, 2020

Teladoc and these two e-commerce leaders are well-positioned to turn in serious returns during the years to come.

Why Teladoc Stock Was Sinking Today

From The Motley Fool May 27, 2020

Shares of the telehealth provider continued to fall as the market rotated out of high-growth stocks.

5 Health Care Stocks to Bet on as Coronavirus Woes Linger

From Zacks Investment Research May 27, 2020

The health care industry has been rallying so far this year on constant testing and COVID-19 vaccine trials.